Loading clinical trials...
Loading clinical trials...
The Effect of Lactobacillus Rhamnosus (LGG®) on the Defence Against Pathogens in the Upper Respiratory Tract in Healthy Children - a Single-center, Randomized, Double-blind, Placebo-controlled Study With 16 Weeks Intervention.
Conditions
Interventions
Probiotic strain
Placebo
Locations
1
United Kingdom
CPS Research
Glasgow, United Kingdom
Start Date
September 1, 2018
Primary Completion Date
April 13, 2019
Completion Date
August 30, 2019
Last Updated
July 10, 2020
Lead Sponsor
Chr Hansen
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions